| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-409X(02)00021-2 |
| P698 | PubMed publication ID | 12052708 |
| P2093 | author name string | Frank F Davis | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 457-8 | |
| P577 | publication date | 2002-06-17 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | The origin of pegnology | |
| P478 | volume | 54 |
| Q47723258 | Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo |
| Q35535519 | Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy |
| Q38652655 | Bioanalytical approaches to assess the proteolytic stability of therapeutic fusion proteins |
| Q81610160 | Biofunctionalized targeted nanoparticles for therapeutic applications |
| Q38734878 | Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles |
| Q36917982 | Biomedical interfaces: titanium surface technology for implants and cell carriers |
| Q57373258 | Biosynthetic-Synthetic Polymer Conjugates |
| Q30354932 | Brain delivery of proteins via their fatty acid and block copolymer modifications |
| Q51376933 | Calprotectin Pegylation Enhanced Its Physical and Structural Properties. |
| Q53540613 | Charge-conversional and pH-sensitive PEGylated polymeric micelles as efficient nanocarriers for drug delivery. |
| Q61797303 | Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review |
| Q59318878 | Controlled-release formulation of perindopril erbumine loaded PEG-coated magnetite nanoparticles for biomedical applications |
| Q36374363 | Design of non-standard insulin analogs for the treatment of diabetes mellitus |
| Q37801381 | Drug delivery technologies for autoimmune disease |
| Q33282118 | Effect of the physicochemical properties of poly(ethylene glycol) brushes on their binding to cells |
| Q83067154 | Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS |
| Q57947018 | Engineering Proteins at Interfaces: From Complementary Characterization to Material Surfaces with Designed Functions |
| Q47263594 | Evolution and Clinical Translation of Drug Delivery Nanomaterials |
| Q39655348 | HPMA Copolymer-Aminohexylgeldanamycin Conjugates Targeting Cell Surface Expressed GRP78 in Prostate Cancer |
| Q35682204 | In Vivo Remote Control of Reactions in Caenorhabditis elegans by Using Supramolecular Nanohybrids of Carbon Nanotubes and Liposomes |
| Q64963029 | Introduction to Nanomedicine. |
| Q48361564 | Lessons in simplicity that should shape the future of drug delivery |
| Q51371022 | Magnetically and Near-Infrared Light-Powered Supramolecular Nanotransporters for the Remote Control of Enzymatic Reactions. |
| Q38987392 | Materials and methods for delivery of biological drugs |
| Q38011258 | Micelle-like nanoassemblies based on polymer-drug conjugates as an emerging platform for drug delivery |
| Q36214907 | Multifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents |
| Q34534023 | NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY. |
| Q34655287 | Nanoparticles in medicine: therapeutic applications and developments |
| Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
| Q34230175 | Nanopharmaceuticals (part 1): products on the market |
| Q36842770 | Nanotechnology for targeted cancer therapy |
| Q33364520 | PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile |
| Q38167826 | PEGylated nanomedicines: recent progress and remaining concerns |
| Q38269324 | PEGylation and its impact on the design of new protein-based medicines. |
| Q40456028 | Poly(2-oxazoline) hydrogels as next generation three-dimensional cell supports |
| Q36561667 | Polymer conjugates as anticancer nanomedicines |
| Q38645927 | Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century |
| Q36648444 | Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities |
| Q33773418 | Polymeric nanomedicine for cancer MR imaging and drug delivery |
| Q36494142 | Polymers for gene delivery across length scales. |
| Q57635944 | Production of PEGylated Proteins |
| Q90543534 | Protein-polymer bioconjugates via a versatile oxygen tolerant photoinduced controlled radical polymerization approach |
| Q44970118 | Purification and analysis of mono-PEGylated HSA by hydrophobic interaction membrane chromatography |
| Q51307074 | Quantification of Paclitaxel and Polyaspartate Paclitaxel Conjugate in Beagle Plasma: Application to a Pharmacokinetic Study. |
| Q39873136 | S-layer fusion protein as a tool functionalizing emulsomes and CurcuEmulsomes for antibody binding and targeting. |
| Q55021294 | Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy. |
| Q35814108 | Structure-immunogenicity relationships of therapeutic proteins |
| Q35128900 | The dawning era of polymer therapeutics |
Search more.